Carter's (CRI) PT Lowered to $56 at Wedbush
Tweet
Share
E-mailGet Alerts CRI Hot Sheet
Price: $41.57 -2.28%
Rating Summary:
9 Buy, 11 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
9 Buy, 11 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Wedbush analyst Tom Nikic lowered the price target on Carter's (NYSE: CRI) to $56.00 (from $74.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Wells Fargo Upgrades Carter's (CRI) to Equal Weight
- Deutsche Bank Downgrades Apogee Therapeutics Inc (APGE) to Hold
- Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
